The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


200 Units/ml Solution for Injection

Eli Lilly and Company LimitedEU/1/96/007/039-042

Main Information

Active Substances
Strength200 Units/ml
Dosage FormSolution for Injection
Licence HolderEli Lilly and Company Limited
Licence NumberEU/1/96/007/039-042

Group Information

ATC CodeA10AB04 insulin lispro


Licence Issued30/09/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - Patient

« Back